LATE-BREAKING ABSTRACT: Simtuzumab in idiopathic pulmonary fibrosis: Results of a randomized clinical trial
Thomas O'Riordan (Seattle, United States of America), Ganesh Raghu, Kevin Brown, Harold Collard, David Lederer, Fernando Martinez, Paul Noble, Jin Woo Song, Athol Wells, Timothy Whelan, Emmanuel Moreau, Scott Patterson, Selina Bayly, Jason Chien, Jennifer Zhang, Thomas O’Riordan
Source: International Congress 2016 – IPF treatment I
Session: IPF treatment I
Session type: Oral Presentation
Number: 1807
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thomas O'Riordan (Seattle, United States of America), Ganesh Raghu, Kevin Brown, Harold Collard, David Lederer, Fernando Martinez, Paul Noble, Jin Woo Song, Athol Wells, Timothy Whelan, Emmanuel Moreau, Scott Patterson, Selina Bayly, Jason Chien, Jennifer Zhang, Thomas O’Riordan. LATE-BREAKING ABSTRACT: Simtuzumab in idiopathic pulmonary fibrosis: Results of a randomized clinical trial. Eur Respir J 2016; 48: Suppl. 60, 1807
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: